eickelbergmd.bsky.social
@eickelbergmd.bsky.social
Thanks for inviting us to @yalepccsm.bsky.social 🙏. Wonderful to meet you and so many friends!
Was so great to have one of my most favorite pulmonary power couples in the world! Their talks were amazing, insights numerous. meetings and discussions inspiring and stimulating and dinners epic!!
❤️🙏🏼#MelanieAndOliver🙏🏼❤️
#ScienceMatters
#FriendshipMatters
April 10, 2025 at 3:02 AM
Reposted
Our current issue's special collection of Physician-Scientist Development articles includes an editorial by Editor in chief @eickelbergmd.bsky.social & is paired with a cover collage of children's drawings illustrating what a 'physician-scientist' means to them: buff.ly/mWGTpMV
April 8, 2025 at 5:38 PM
Reposted
@markesnyder.bsky.social et al. flip the script on our understanding of infection and rejection after transplantation– they show that systemic NKG2D blockade can impair airway-associated Tissue resident memory T cell accumulation and reduce CLAD severity: buff.ly/61mpbwk
March 6, 2025 at 4:13 PM
Reposted
Just published @science.org
A basis—lung inflammation—for #LongCovid (PASC) in the experimental model, and a potential therapy
[driven by alveolar macrophages and loss of their peroxisomes (Figure)]
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...
March 6, 2025 at 7:00 PM
Reposted
Emanual Maverakis et al. use single-cell and bulk RNA-seq and immunohistochemistry to characterize necrobiosis and identified SPP1 and CCL5 as novel therapeutic targets for NL and NXG, rare diseases without a highly effective therapy: buff.ly/7htsyLe
March 4, 2025 at 4:13 PM
Reposted
December 14, 2024 at 2:04 AM